As Mastercard (MA) Stock Price Rose, Holder Fuller & Thaler Asset Management Has Cut Its Stake; First Manhattan Company Increases Position in Teva Pharmaceutical (TEVA)

February 21, 2018 - By Kurt Siggers

Fuller & Thaler Asset Management Inc decreased its stake in Mastercard Inc (MA) by 32.14% based on its latest 2017Q3 regulatory filing with the SEC. Fuller & Thaler Asset Management Inc sold 4,500 shares as the company’s stock rose 7.46% with the market. The institutional investor held 9,500 shares of the business services company at the end of 2017Q3, valued at $1.34M, down from 14,000 at the end of the previous reported quarter. Fuller & Thaler Asset Management Inc who had been investing in Mastercard Inc for a number of months, seems to be less bullish one the $183.29B market cap company. The stock decreased 0.58% or $1.02 during the last trading session, reaching $174.33. About 1.63M shares traded. Mastercard Incorporated (NYSE:MA) has risen 24.16% since February 21, 2017 and is uptrending. It has outperformed by 7.46% the S&P500.

First Manhattan Company increased its stake in Teva Pharmaceutical (TEVA) by 2.01% based on its latest 2017Q3 regulatory filing with the SEC. First Manhattan Company bought 30,306 shares as the company’s stock declined 15.11% while stock markets rallied. The hedge fund held 1.54M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $27.09 million, up from 1.51M at the end of the previous reported quarter. First Manhattan Company who had been investing in Teva Pharmaceutical for a number of months, seems to be bullish on the $20.56 billion market cap company. The stock increased 1.18% or $0.235 during the last trading session, reaching $20.215. About 5.06 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 21, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

First Manhattan Company, which manages about $20.51B and $17.46 billion US Long portfolio, decreased its stake in Spirit Airlines In (NASDAQ:SAVE) by 69,615 shares to 18,820 shares, valued at $628,000 in 2017Q3, according to the filing. It also reduced its holding in Discover Finl Svcs (NYSE:DFS) by 104,175 shares in the quarter, leaving it with 461,973 shares, and cut its stake in Wabco Holdings (NYSE:WBC).

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) rating on Thursday, August 3. Cantor Fitzgerald has “Hold” rating and $2700 target. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Sell” rating given on Monday, November 13 by J.P. Morgan. RBC Capital Markets maintained the stock with “Sell” rating in Wednesday, November 29 report. The company was maintained on Thursday, October 26 by Mizuho. Oppenheimer maintained the shares of TEVA in report on Friday, April 7 with “Buy” rating. Citigroup maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Monday, November 13 with “Neutral” rating. Jefferies maintained the shares of TEVA in report on Tuesday, September 12 with “Hold” rating. The stock has “Buy” rating by Susquehanna on Thursday, January 25. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Underweight” rating given on Thursday, October 5 by Morgan Stanley. Standpoint Research maintained the shares of TEVA in report on Monday, July 27 with “Buy” rating.

Analysts await Mastercard Incorporated (NYSE:MA) to report earnings on May, 1. They expect $1.25 earnings per share, up 23.76% or $0.24 from last year’s $1.01 per share. MA’s profit will be $1.31 billion for 34.87 P/E if the $1.25 EPS becomes a reality. After $1.14 actual earnings per share reported by Mastercard Incorporated for the previous quarter, Wall Street now forecasts 9.65% EPS growth.

Investors sentiment increased to 0.89 in 2017 Q3. Its up 0.01, from 0.88 in 2017Q2. It improved, as 39 investors sold MA shares while 488 reduced holdings. 103 funds opened positions while 367 raised stakes. 779.91 million shares or 1.33% less from 790.40 million shares in 2017Q2 were reported. Ing Groep Nv holds 473,702 shares or 1.29% of its portfolio. Ativo Cap Limited Liability Corporation holds 21,784 shares or 0.83% of its portfolio. Hall Laurie J Trustee reported 14,450 shares. Marshall & Sullivan Wa has invested 2.65% in Mastercard Incorporated (NYSE:MA). Wealthfront invested 0.07% in Mastercard Incorporated (NYSE:MA). Summit Wealth Advsr Limited Liability Co holds 0.09% or 1,848 shares. Jacobus Wealth Mngmt Inc, Wisconsin-based fund reported 1,415 shares. Banced Corporation accumulated 6,750 shares or 1.66% of the stock. Mirae Asset Communications holds 1.14% or 443,589 shares in its portfolio. Olstein Capital Ltd Partnership invested in 0.68% or 37,615 shares. Blue Ridge Limited Liability Co reported 678,170 shares. Polar Llp holds 66,556 shares or 0.11% of its portfolio. Ancora Limited Liability Com holds 0.34% of its portfolio in Mastercard Incorporated (NYSE:MA) for 40,942 shares. Altarock Prtn Limited Liability Company owns 8.22% invested in Mastercard Incorporated (NYSE:MA) for 398,290 shares. Riverpoint Mngmt Lc, Ohio-based fund reported 4,219 shares.

Among 40 analysts covering Mastercard Incorporated (NYSE:MA), 36 have Buy rating, 0 Sell and 4 Hold. Therefore 90% are positive. Mastercard Incorporated had 121 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Susquehanna with “Buy” on Thursday, February 1. The firm earned “Buy” rating on Thursday, February 1 by RBC Capital Markets. The firm earned “Buy” rating on Friday, September 8 by Nomura. The rating was maintained by Tigress Financial on Thursday, February 8 with “Buy”. RBC Capital Markets maintained Mastercard Incorporated (NYSE:MA) rating on Tuesday, August 29. RBC Capital Markets has “Buy” rating and $140.0 target. The stock of Mastercard Incorporated (NYSE:MA) has “Outperform” rating given on Friday, September 8 by Credit Suisse. As per Monday, October 31, the company rating was maintained by Compass Point. The stock of Mastercard Incorporated (NYSE:MA) earned “Buy” rating by Cowen & Co on Thursday, July 27. As per Thursday, December 28, the company rating was maintained by Susquehanna. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, July 27.

Fuller & Thaler Asset Management Inc, which manages about $2.14B and $8.17 billion US Long portfolio, upped its stake in Marcus & Millichap Inc (NYSE:MMI) by 22,100 shares to 30,100 shares, valued at $812,000 in 2017Q3, according to the filing. It also increased its holding in Verint Systems Inc (NASDAQ:VRNT) by 181,583 shares in the quarter, for a total of 1.97 million shares, and has risen its stake in Visteon Corp (NYSE:VC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.